Sept 11 (Reuters) - Medical device maker Medtronic Plc said on Monday it would recall certain infusion sets used with its insulin pumps by diabetes patients due to a component that could cause death in extreme cases.
Infusion sets help connect an insulin pump device to the body.
Medtronic said the vent membrane in some of its infusion sets could be blocked by fluid during the process of priming, or removal of air bubbles, potentially leading to insulin being over-delivered.
Over-delivery of insulin can cause hypoglycemia or low blood sugar and in extreme cases, death.
Medtronic said it had discontinued the affected vent membranes in the infusion sets.
The Dublin-based company received reports of hypoglycemia requiring medical intervention, potentially linked to the issue, Medtronic said.
Medtronic did not provide the number of infusion sets being recalled.
The company in April recalled devices used to manage build-up of the cerebrospinal fluid that surrounds the brain due to increased complaints. (Reporting by Manas Mishra in Bengaluru; Editing by Savio D’Souza and Sai Sachin Ravikumar)